CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-08-08. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 2471 · Search date 2026-08-08 · Methodology v1.0

Comprehensive COPD self-management program,
does it really help with Reduced COPD-related hospitalization?

30-Second Summary
D
Evidence Grade D · 34 · Safety warning
Hospitalization did not fall and the trial stopped after excess mortality.
All-cause mortality was significantly higher and the trial was stopped for safety. Exacerbation action plans require clinician supervision and must not delay urgent evaluation.
What the
research shows
The grade is D. In 426 patients, one-year cumulative COPD hospitalization was 27% versus 24%, HR 1.13 (95% CI 0.70-1.80). Deaths were 28/209 versus 10/217, HR 3.00 (1.46-6.17), and the trial stopped early for safety.
What the
ads claim
COPD education remains part of care, but this specific package should not be sold as proven hospitalization prevention.
*

Useful facts when choosing a product

  • The package combined five education sessions, an action plan, and scheduled case management.
  • The registered and published primary outcomes matched.
  • Funding came from the US Department of Veterans Affairs Cooperative Studies Program.
ID

Chamgap Semantic Classification Code

Candidate index · review held

X.comprehensive-copd-self-management-program-combining-education.behavioral.copd-related-hospitalization.reduce.MULTI

Behaviors, exposures and policies > comprehensive COPD self-management program combining education > Behavioral delivery > COPD-related hospitalization > Reduction claim > Multiple: primary unresolved

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 2471 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The intervention comprised four individual sessions, one group session, an exacerbation action plan, and proactive scheduled calls. Control was guideline-based usual care plus an information booklet. Allocation-concealment implementation and evidence that participant masking held were not reported in the publicly checked text.

02

Why this is classified as D (34)

A null primary outcome, prespecified mortality harm, and early termination give D with 34 points.

Counterpoint. The cause of excess mortality remained unexplained and does not indict all COPD education.

Rejudgment record. Cross-check applied — Null registered primary hospitalization outcome, prespecified mortality increase, and safety stopping

Stored scoring profile
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE-Harm increased in the trials
PrecisionC0The confidence interval leaves room for benefit

Stored derived and displayed grades match; this is not a current recalculation or validity check (D).

▦

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced COPD-related hospitalizationDThe result was null: 27% versus 24%, HR 1.13.
All-cause mortality safetyDMortality increased significantly, 28 versus 10.
✓

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Fan VS et al. 201220-site VA randomized controlled trial stopped early for safety426 randomized (209/217), 44% of the planned 960Department of Veterans Affairs Cooperative Studies ProgramPrimary: time to first COPD hospitalization; secondary: all-cause mortalityHospitalization 27% vs 24%, HR 1.13 (0.70-1.80); deaths 28 vs 10, HR 3.00 (1.46-6.17); mean follow-up 250 daysPivotal publicly funded trial
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-08).

Fan VS, Gaziano JM, Lew R, et al. Ann Intern Med. 2012;156:673-683. PMID: 22586006. DOI: 10.7326/0003-4819-156-10-201205150-00003.
checked
ClinicalTrials.gov. NCT00395083.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-08-08 · Corrections: none
↗

Cite this verdict

Comprehensive COPD self-management program x reduced hospitalization Evidence Grade D card
[Chamgap] Comprehensive COPD self-management program x reduced hospitalization — Evidence Grade D·34. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/energy/copd-comprehensive-self-management-hospitalization/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.
↑